In our weekly interview with a top Investing Daily analyst, we discuss a wide range of topical issues of crucial importance to investors. Read More
Analyst Articles
Visa is the largest credit card payment outfit in the U.S. Will the stock continue its winning streak this year or will tech "disruptors" knock the company off its perch? Read More
The rising incidence of hacking dominates the front pages. We examine cybersecurity firm Bravatek to see if it's a growth play or just another risky fad stock. Read More
This mid-cap biotech is developing novel drugs for diseases that resist conventional therapies. Is Arena a future "rocket stock" or will it blow up on the launch pad? Read More
This cannabis biotech is a micro-cap garnering Wall Street's attention. As investors flock to pot investments, is United Cannabis an appealing play or risky penny stock? Read More
Hemp (OTC: HEMP) uses the sturdy fibers of the hemp plant to create industrial products. Is this "picks-and-shovels" cannabis play a worthy investment or risky penny stock? Read More
This maker of cannabis-related recreational and medical products enjoys tailwinds as cannabis legalization continues apace. But is it an overly risky penny stock? Read More
Is this cannabis company a viable enterprise or just another penny stock booby trap? We examine whether Abattis is a small-cap value play or toxic investment. Read More
Florida, with its growing population of retired baby boomers and easy-going subtropical culture, is a thriving mecca for marijuana companies. Cannabis sales are growing quickly throughout the U.S., but pot demand is especially strong in the Sunshine State. This unstoppable multi-year trend explains why Trulieve Cannabis (CSE: TRUL, OTC: TCNNF)… Read More
Cashless payment purveyor USA Technologies decisively answered regulator questions on Monday, reassuring jittery investors and boosting the share price. Read More